Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Off label use? 91 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Off label use have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 51.7% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
91
Reports of Off label use with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
51.7%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
89
Hospitalizations
How Dangerous Is Off label use From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 91 reports, 89 (97.8%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 91 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Erythema (127)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Off label use Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX